Mark Gardner > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Mark Gardner
Work Department
Antitrust and Competition
Position
Mark Gardner is a partner in the Antitrust and Competition team based in London. He advises on a wide range of merger control, antitrust and compliance issues.
Mark has particular experience advising on EU and multi-jurisdictional merger control, representing a range of clients including corporations and financial investors.
In addition to his antitrust and competition work, Mark also advises on foreign investment controls, including the UK National Security and Investment Act.
Career
2017 to present Kirkland & Ellis International LLP; 2008-2017 Arnold & Porter LLP; 2005-2008 SJ Berwin LLP
Education
King’s College London (M.A. 2009); Nottingham Law School (LPC 2002); University of Reading (LL.B. 2001)
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium